Dr. Cloé Cherif Vrignaud is a French pharmacist (PharmD) specializing in cannabinoid science and the Endocannabinoid System (ECS) since 2014. Inspired by her own experience managing a rare disease with medical cannabis, she has dedicated her career to advancing cannabinoid-based therapies, functional medicine, and holistic healthcare.

An international speaker and educator, she trains healthcare professionals on cannabinoid science, ECS research, sleep disorders, and mental health. Dr. Cherif Vrignaud advocates for preventive, evidence-based approaches that improve patient outcomes and address emerging public health challenges.

She is the founder of Citanna Pharma Group and Doussia, where she is developing innovative cannabinoid wellness and functional healthcare solutions aimed at becoming a leading reference across Europe.